IRIS Accounts Production v25.3.0.601 05110938 Board of Directors 1.10.24 30.9.25 30.9.25 false true false false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 05110938 2024-09-30 05110938 2025-09-30 05110938 2024-10-01 2025-09-30 05110938 2023-09-30 05110938 2023-10-01 2024-09-30 05110938 2024-09-30 05110938 ns15:EnglandWales 2024-10-01 2025-09-30 05110938 ns14:PoundSterling 2024-10-01 2025-09-30 05110938 ns10:Director1 2024-10-01 2025-09-30 05110938 ns10:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 05110938 ns10:SmallEntities 2024-10-01 2025-09-30 05110938 ns10:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 05110938 ns10:SmallCompaniesRegimeForDirectorsReport 2024-10-01 2025-09-30 05110938 ns10:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 05110938 ns10:FullAccounts 2024-10-01 2025-09-30 05110938 1 2024-10-01 2025-09-30 05110938 ns10:Director2 2024-10-01 2025-09-30 05110938 ns10:RegisteredOffice 2024-10-01 2025-09-30 05110938 ns5:CurrentFinancialInstruments 2025-09-30 05110938 ns5:CurrentFinancialInstruments 2024-09-30 05110938 ns5:Non-currentFinancialInstruments 2025-09-30 05110938 ns5:Non-currentFinancialInstruments 2024-09-30 05110938 ns5:ShareCapital 2025-09-30 05110938 ns5:ShareCapital 2024-09-30 05110938 ns5:RetainedEarningsAccumulatedLosses 2025-09-30 05110938 ns5:RetainedEarningsAccumulatedLosses 2024-09-30 05110938 ns5:NetGoodwill 2024-10-01 2025-09-30 05110938 ns5:LeaseholdImprovements 2024-10-01 2025-09-30 05110938 ns5:PlantMachinery 2024-10-01 2025-09-30 05110938 ns5:FurnitureFittings 2024-10-01 2025-09-30 05110938 ns5:MotorVehicles 2024-10-01 2025-09-30 05110938 ns5:ComputerEquipment 2024-10-01 2025-09-30 05110938 ns5:NetGoodwill 2024-09-30 05110938 ns5:NetGoodwill 2025-09-30 05110938 ns5:NetGoodwill 2024-09-30 05110938 ns5:LeaseholdImprovements 2024-09-30 05110938 ns5:PlantMachinery 2024-09-30 05110938 ns5:FurnitureFittings 2024-09-30 05110938 ns5:LeaseholdImprovements 2025-09-30 05110938 ns5:PlantMachinery 2025-09-30 05110938 ns5:FurnitureFittings 2025-09-30 05110938 ns5:LeaseholdImprovements 2024-09-30 05110938 ns5:PlantMachinery 2024-09-30 05110938 ns5:FurnitureFittings 2024-09-30 05110938 ns5:MotorVehicles 2024-09-30 05110938 ns5:ComputerEquipment 2024-09-30 05110938 ns5:MotorVehicles 2025-09-30 05110938 ns5:ComputerEquipment 2025-09-30 05110938 ns5:MotorVehicles 2024-09-30 05110938 ns5:ComputerEquipment 2024-09-30 05110938 ns5:CostValuation 2024-09-30 05110938 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-09-30 05110938 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-09-30 05110938 ns5:WithinOneYear ns5:CurrentFinancialInstruments ns5:HirePurchaseContracts 2025-09-30 05110938 ns5:WithinOneYear ns5:CurrentFinancialInstruments ns5:HirePurchaseContracts 2024-09-30 05110938 ns5:HirePurchaseContracts ns5:BetweenOneFiveYears 2025-09-30 05110938 ns5:HirePurchaseContracts ns5:BetweenOneFiveYears 2024-09-30 05110938 ns5:HirePurchaseContracts 2025-09-30 05110938 ns5:HirePurchaseContracts 2024-09-30 05110938 ns5:WithinOneYear 2025-09-30 05110938 ns5:WithinOneYear 2024-09-30 05110938 ns5:BetweenOneFiveYears 2025-09-30 05110938 ns5:BetweenOneFiveYears 2024-09-30 05110938 ns5:MoreThanFiveYears 2025-09-30 05110938 ns5:MoreThanFiveYears 2024-09-30 05110938 ns5:AllPeriods 2025-09-30 05110938 ns5:AllPeriods 2024-09-30 05110938 ns5:Secured 2025-09-30 05110938 ns5:Secured 2024-09-30

REGISTERED NUMBER: 05110938 (England and Wales)

Financial Statements for the Year Ended 30 September 2025

for

Pharm-Assist (Healthcare) Limited

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Contents of the Financial Statements

for the Year Ended 30 September 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

Pharm-Assist (Healthcare) Limited

Company Information

for the Year Ended 30 September 2025

| DIRECTORS: | A D Cohen

| N L Cohen

| REGISTERED OFFICE: | 23 Oakwood Grove

| Oakwood

| Leeds

| West Yorkshire

| LS8 2PA

| REGISTERED NUMBER: | 05110938 (England and Wales)

| ACCOUNTANTS: | Richard Smedley Limited

| Chartered Accountants & Registered Auditors

| Richmond House

| Lawnswood Business Park

| Redvers Close

| Leeds

| West Yorkshire

| LS16 6QY

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Balance Sheet

30 September 2025

| 30.9.25 | 30.9.24 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 4 | 237,327 |  | 801,051 |  |

Tangible assets | 5 | 120,914 |  | 156,953 |  |

Investments | 6 | 1,152,333 |  | 1,152,333 |  |

1,510,574 |  | 2,110,337 |  |

CURRENT ASSETS

Stocks | 169,240 |  | 224,587 |  |

Debtors | 7 | 650,626 |  | 569,523 |  |

Cash at bank and in hand | 43,137 |  | 2,631 |  |

863,003 |  | 796,741 |  |

CREDITORS

Amounts falling due within one year | 8 | 843,566 |  | 1,192,944 |  |

NET CURRENT ASSETS/(LIABILITIES) | 19,437 |  | (396,203 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 1,530,011 |  | 1,714,134 |  |

CREDITORS

Amounts falling due after more than one year | 9 | (1,501,122 | ) | (1,672,918 | ) |

PROVISIONS FOR LIABILITIES | (18,420 | ) | (36,145 | ) |

NET ASSETS | 10,469 |  | 5,071 |  |

CAPITAL AND RESERVES

Called up share capital | 1,000 |  | 1,000 |  |

Retained earnings | 9,469 |  | 4,071 |  |

SHAREHOLDERS' FUNDS | 10,469 |  | 5,071 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Balance Sheet - continued

30 September 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 April 2026 and were signed on its behalf by:

A D Cohen - Director

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Notes to the Financial Statements

for the Year Ended 30 September 2025

1. | STATUTORY INFORMATION

| Pharm-Assist (Healthcare) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover comprises the value of sales (excluding VAT, similar taxes and trade discounts) of goods and services provided in the normal course of business. Counter sales and prescriptions are recognised when the goods are dispensed.

| Goodwill

| Goodwill, being the amount paid in connection with the acquisition of businesses in 2006 and 2008, has undergone an impairment review during the year, the effect of which being no amortisation. The recent purchase of goodwill done in 2019 is to be amortised evenly over 10 years as this business has a different lifespan.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Improvements to property | - | 15% on cost and Straight line over 15 years

| Plant and machinery | - | 10% on cost

| Fixtures and fittings | - | 15% on cost

| Motor vehicles | - | 25% on reducing balance

| Computer equipment | - | 50% on cost

| Investments in subsidiaries

| Investments in subsidiary undertakings are recognised at cost.

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Financial instruments

| Financial assets are measured at fair value through profit or loss.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Notes to the Financial Statements - continued

for the Year Ended 30 September 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 33 (2024 - 35 ) .

4. | INTANGIBLE FIXED ASSETS

| Goodwill

£ |

| COST

| At 1 October 2024 | 1,367,980 |  |

| Disposals | (932,178 | ) |

| At 30 September 2025 | 435,802 |  |

| AMORTISATION

| At 1 October 2024 | 566,929 |  |

| Amortisation for year | 22,455 |  |

| Eliminated on disposal | (390,909 | ) |

| At 30 September 2025 | 198,475 |  |

| NET BOOK VALUE

| At 30 September 2025 | 237,327 |  |

| At 30 September 2024 | 801,051 |  |

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Notes to the Financial Statements - continued

for the Year Ended 30 September 2025

5. | TANGIBLE FIXED ASSETS

| Improvements |  | Fixtures

| to |  | Plant and |  | and

| property |  | machinery |  | fittings

£ | £ | £ |

| COST

| At 1 October 2024 | 38,593 |  | 196,637 |  | 115,375 |  |

| Additions | - |  | - |  | 2,370 |  |

| Disposals | (11,748 | ) | - |  | (12,487 | ) |

| At 30 September 2025 | 26,845 |  | 196,637 |  | 105,258 |  |

| DEPRECIATION

| At 1 October 2024 | 21,139 |  | 69,203 |  | 109,190 |  |

| Charge for year | 654 |  | 19,665 |  | 2,305 |  |

| Eliminated on disposal | (1,582 | ) | - |  | (12,487 | ) |

| At 30 September 2025 | 20,211 |  | 88,868 |  | 99,008 |  |

| NET BOOK VALUE

| At 30 September 2025 | 6,634 |  | 107,769 |  | 6,250 |  |

| At 30 September 2024 | 17,454 |  | 127,434 |  | 6,185 |  |

| Motor |  | Computer |

| vehicles |  | equipment |  | Totals

£ | £ | £ |

| COST

| At 1 October 2024 | 17,708 |  | 53,417 |  | 421,730 |  |

| Additions | - |  | 524 |  | 2,894 |  |

| Disposals | (17,708 | ) | - |  | (41,943 | ) |

| At 30 September 2025 | - |  | 53,941 |  | 382,681 |  |

| DEPRECIATION

| At 1 October 2024 | 14,208 |  | 51,037 |  | 264,777 |  |

| Charge for year | - |  | 2,643 |  | 25,267 |  |

| Eliminated on disposal | (14,208 | ) | - |  | (28,277 | ) |

| At 30 September 2025 | - |  | 53,680 |  | 261,767 |  |

| NET BOOK VALUE

| At 30 September 2025 | - |  | 261 |  | 120,914 |  |

| At 30 September 2024 | 3,500 |  | 2,380 |  | 156,953 |  |

| The net book value of assets held under hire purchase contracts is £103,950 (2024: £122,850.)

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Notes to the Financial Statements - continued

for the Year Ended 30 September 2025

6. | FIXED ASSET INVESTMENTS

| Shares in

| group

| undertakings

£ |

| COST

| At 1 October 2024

| and 30 September 2025 | 1,152,333 |  |

| NET BOOK VALUE

| At 30 September 2025 | 1,152,333 |  |

| At 30 September 2024 | 1,152,333 |  |

7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 30.9.25 |  | 30.9.24

£ | £ |

| Trade debtors | 308,865 |  | 328,947 |  |

| Other debtors | 341,761 |  | 240,576 |  |

650,626 |  | 569,523 |  |

8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 30.9.25 |  | 30.9.24

£ | £ |

| Bank loans and overdrafts | 129,171 |  | 153,152 |  |

| Hire purchase contracts (see note 10) | 29,543 |  | 31,144 |  |

| Trade creditors | 525,734 |  | 661,720 |  |

| Taxation and social security | 11,179 |  | 32,547 |  |

| Other creditors | 147,939 |  | 314,381 |  |

843,566 |  | 1,192,944 |  |

9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

| 30.9.25 |  | 30.9.24

£ | £ |

| Bank loans | 1,501,122 |  | 1,643,374 |  |

| Hire purchase contracts (see note 10) | - |  | 29,544 |  |

1,501,122 |  | 1,672,918 |  |

| Amounts falling due in more than five years:

| Repayable by instalments

| Bank loans more than 5 years | 1,351,580 |  | 1,330,801 |  |

Pharm-Assist (Healthcare) Limited (Registered number: 05110938)

Notes to the Financial Statements - continued

for the Year Ended 30 September 2025

10. | LEASING AGREEMENTS

| Minimum lease payments fall due as follows:

| Hire purchase |

| contracts |

| 30.9.25 |  | 30.9.24 |

£ | £ |

| Net obligations repayable:

| Within one year | 29,543 |  | 31,144 |  |

| Between one and five years | - |  | 29,544 |  |

29,543 |  | 60,688 |  |

| Non-cancellable |

| operating leases |

| 30.9.25 |  | 30.9.24

£ | £ |

| Within one year | 21,900 |  | 31,526 |  |

| Between one and five years | 87,600 |  | 115,600 |  |

| In more than five years | 136,875 |  | 209,525 |  |

246,375 |  | 356,651 |  |

11. | SECURED DEBTS

| The following secured debts are included within creditors:

| 30.9.25 |  | 30.9.24

£ | £ |

| Bank loans | 1,630,293 |  | 1,721,518 |  |

| Hire purchase contracts | 29,543 |  | 60,688 |  |

1,659,836 |  | 1,782,206 |  |

| On 30 August 2022 Unity Trust Bank plc took a fixed and floating charge over Seacroft, Halton and Priory pharmacies. Also contains a negative pledge.